Vanguard Group Inc Merck & Co., Inc. Transaction History
Vanguard Group Inc
- $6.57 Trillion
- Q4 2025
A detailed history of Vanguard Group Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 254,322,763 shares of MRK stock, worth $23.6 Billion. This represents 0.36% of its overall portfolio holdings.
Number of Shares
254,322,763
Previous 252,136,910
0.87%
Holding current value
$23.6 Billion
Previous $21.2 Billion
11.6%
% of portfolio
0.36%
Previous 0.33%
Shares
20 transactions
Others Institutions Holding MRK
# of Institutions
3,968Shares Held
1.9BCall Options Held
29.9MPut Options Held
27.3M-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA53.7MShares$4.99 Billion0.75% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...